This Article  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

MARK C. WEISSLER, MD
Chapel Hill, NC

Arch Otolaryngol Head Neck Surg. 1989;115(10):1162.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

At the 31st annual meeting of the American Society for Head and Neck Surgery, held in San Francisco, Calif, April 5 and 6, 1989, Drs Scott Stern and James Suen, Little Rock, Ark, reported a retrospective study of the use of adjuvant radiotherapy in 30 patients with mucosal and advanced or recurrent cutaneous head and neck melanoma. Of 7 patients with mucosal melanoma, all treated with surgery and conventional postoperative radiotherapy, all died of disease within 16 months. The local control rate was 71% (5/7). In the 23 patients with advanced or recurrent cutaneous melanoma, the local control rate was 53% (9/17) in the group receiving a high dose per fraction of hypofractionated adjuvant radiotherapy vs 100% (6/6) in the group receiving conventionally fractionated adjuvant radiotherapy. The investigators interpreted these data to show that conventionally fractionated adjuvant radiotherapy is probably effective in obtaining local control of advanced head and neck melanoma . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?